AME - Educational Analysis * US Equities
Educational Analysis * US Equities

AME

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerAME
CategoryEducational primer
Last reviewedOctober 27, 2026

Business Profile & Competitive Position

AMETEK, Inc. operates in the Industrials sector, specifically the Electrical Equipment & Parts industry. The company describes itself as a global manufacturer of electronic instruments and electromechanical devices, organized into two segments: Electronic Instruments (EIG) and Electromechanical (EMG). EIG produces advanced analytical, test and measurement instruments sold into process, aerospace, power and industrial end markets. EMG supplies precision motion control systems, medical components and devices, thermal management systems, specialty metals and electrical interconnects to aerospace and defense, medical, automation and broader industrial customers.

Competitive quality can be read directly from the company’s returns. AMETEK posts a 20.0% net margin and a 14.5% return on equity. In a capital-goods business that relies on specialized manufacturing, those figures point to more than just volume; they imply durable pricing power, a disciplined cost base and repeated ability to convert revenue into bottom-line profit. The dual-segment structure also matters: roughly half of EIG net sales and a meaningful share of EMG net sales are exported outside the United States, which means AMETEK’s competitive moat is global rather than purely domestic.

Financial Posture

At a $55.7 billion market capitalization and a trailing price-to-earnings ratio of 35.3, AMETEK carries a valuation premium relative to many diversified industrial peers. That multiple suggests the market is pricing in above-average earnings persistence, likely supported by the company’s 20.0% net margin and 14.5% ROE. A P/E of 35.3 means investors are paying roughly thirty-five times each dollar of trailing earnings, so expectations embedded in the price are comparatively high.

Profitability metrics reinforce the valuation story rather than contradict it. The 20.0% net margin is strong for a manufacturer of electrical components and instruments, while the 14.5% ROE indicates effective use of shareholder capital. Beta is listed at 0.96, essentially market-like, so the stock has historically moved in line with broader equity benchmarks rather than showing extreme cyclical sensitivity. There is no debt figure in the supplied data, so any leverage assessment should wait for the full balance sheet; what is visible, however, is a company whose returns justify, at least on paper, a richer-than-average multiple.

Strategic Priorities & Outlook

AMETEK’s most recent 10-K filing outlines a clear operational blueprint. The centerpiece is the AMETEK Growth Model, targeting high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation and a superior return on total capital. Those targets are supported by Operational Excellence initiatives: lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens and the use of digitalization and artificial intelligence to improve productivity.

Acquisition activity is a second pillar. From 2021 through December 31, 2025, AMETEK completed 15 acquisitions representing roughly $1.8 billion in annualized sales. In 2025 alone, the company deployed $933.2 million in cash, net of cash acquired, to buy Kern (high-precision machining and optical inspection solutions) and FARO Technologies (3D measurement and imaging solutions). These deals fit the stated strategy of buying businesses with complementary technology and cultural fit in markets tied to secular growth themes.

Geographic expansion is the third pillar. AMETKE maintains what it calls best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia, designed to keep production close to customers and support international growth. In 2025, AMETEK generated sales of $7,401.1 million, up 6.6% from 2024, and diluted EPS of $6.40, up 7.9%. It also reported record operating income, net income, orders and backlog. As of year-end 2025, AMETEK employed approximately 22,500 people.

Macro & Geopolitical Exposure

Because AMETEK sits in the Electrical Equipment & Parts industry, its exposures are those common to precision manufacturers with global supply chains and aerospace, defense, medical and industrial end markets. Trade policy is a recurring factor: electrical components and instruments move across borders repeatedly, and tariffs or export controls on specialized parts can move costs and margins. Supply-chain resilience matters as well; key inputs include copper, specialty metals, semiconductors and electronic subcomponents, all of which can tighten or rise in price during commodity cycles.

Currency risk is built into the model, with 52% of EIG’s 2025 net sales and 42% of EMG’s 2025 net sales going to customers outside the United States. A stronger U.S. dollar can mechanically reduce the value of overseas revenue when translated back. Regulatory exposure is also relevant: aerospace and defense sales are sensitive to U.S. and allied defense budgets and export licensing, while medical components face FDA or equivalent overseas medical-device regulation. Finally, the company’s manufacturing footprint in China, Czechia, Malaysia, Mexico and Serbia means that local labor, environmental and geopolitical conditions can affect production timing and cost.

Recent Developments

Recent headlines place AMETEK in the pre-earnings window ahead of its November 3, 2026 report. On October 15, 2026, Zacks published “Is AMETEK (AME) Outperforming Other Computer and Technology Stocks This Year?” while PR Newswire carried AMETEK’s announcement of its third-quarter 2026 earnings call and webcasted investor conference call. Also on October 15, 2026, Defense World reported that Krilogy Financial LLC had purchased AMETEK shares. Five days earlier, on October 9, 2026, Defense World noted that GAMMA Investing LLC had bought AMETEK stock. These items do not carry material operational disclosures, but they illustrate the typical pattern of institutional position-building and media attention that often surrounds a stock in the weeks before an earnings release.

Earnings Behavior & Post-Earnings Drift

AMETEK’s earnings record over the last eight reported quarters is spotless: 8 out of 8 beats, with an average earnings surprise of 4%. That consistency does not, however, translate into large directional post-earnings moves. The average 5-day price move after earnings across those quarters is just 0.46%, classified as flat drift. In other words, beats are common, but the market often prices them in quickly.

The most recent quarters illustrate that dynamic. On August 4, 2026, AMETEK reported EPS of $2.09 against an estimate of $1.99, a 5.0% beat; the stock rose 0.28% the next day and 0.89% over the following five days. On April 30, 2026, EPS came in at $1.97 versus $1.90, a 3.7% surprise, yet the next-day reaction was a 2.13% drop and the five-day drift was negative 0.33%. February 3, 2026, saw a $2.01 print against $1.94 (3.6% surprise), with the stock falling 0.48% the next day before drifting up 1.83% over five sessions. October 30, 2025, produced the largest beat in this window—$1.89 versus $1.76, or 7.4%—and the next day’s move was a positive 1.91%, though the five-day drift was negative 0.54%.

Looking ahead, AMETEK is scheduled to report on November 3, 2026, before the market opens, with the current consensus EPS estimate at $2.11. That would represent modest sequential growth from the prior quarter’s $2.09. Because the stock has beaten expectations in every quarter on record here, the unofficial consensus is arguably higher than the published figure; traders often watch guidance and segment margins rather than the headline EPS alone.

Frequently Asked Questions

What does AMETEK actually manufacture?

AMETEK is an Industrials company in the Electrical Equipment & Parts industry. It makes electronic instruments—analytical, test and measurement devices—through its Electronic Instruments Group, and electromechanical products such as precision motion controls, medical components, thermal management systems, specialty metals and electrical interconnects through its Electromechanical Group.

How consistent has AMETEK been at beating earnings estimates?

Over the last eight reported quarters, AMETEK has beaten estimates in all eight, with an average earnings surprise of 4%. Despite that consistency, the average 5-day post-earnings price move is only 0.46%, classified as flat post-earnings drift.

What are AMETEK’s main strategic priorities?

Per its most recent 10-K, AMETEK focuses on executing the AMETEK Growth Model (high-single-digit sales growth, double-digit EPS growth and strong cash flow), advancing operational excellence through lean manufacturing and digitalization, and pursuing strategic acquisitions in adjacent markets. In 2025 it spent $933.2 million acquiring Kern and FARO Technologies.

For a deeper dive, investors should review the full institutional verdict, which aggregates analyst models, target ranges, sector-relative rankings and updated model assumptions beyond the figures shown here.

Real Data - Gamma QC Earnings IntelligenceAs of Oct 27, 2026
AMETEK, Inc. · Industrials / Electrical Equipment & Parts
$55.7BMarket cap
35.3P/E
20.0%Net margin
14.5%ROE
100%Beat rate, last 8Q
4%Avg EPS surprise
0.46%Avg 5-day move after earnings
2026-11-03Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-08-04$2.09$1.99+5%+0.28%+0.89%
2026-04-30$1.97$1.9+3.7%-2.13%-0.33%
2026-02-03$2.01$1.94+3.6%-0.48%+1.83%
2025-10-30$1.89$1.76+7.4%+1.91%-0.54%
2025-07-31$1.78$1.69+5.3%--
2025-05-01$1.75$1.69+3.6%--

Previous AME editions

Beyond the primer

Get the institutional verdict on AME

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the AME verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.